CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 35 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$505,000
-13.7%
9,5540.0%0.00%0.0%
Q2 2020$585,000
+8.3%
9,5540.0%0.00%0.0%
Q1 2020$540,000
+0.4%
9,554
+1.2%
0.00%0.0%
Q4 2019$538,000
+6.5%
9,4450.0%0.00%0.0%
Q3 2019$505,000
-10.5%
9,4450.0%0.00%0.0%
Q2 2019$564,000
+2.0%
9,445
+6.4%
0.00%0.0%
Q1 2019$553,000
-2.6%
8,874
-5.4%
0.00%0.0%
Q4 2018$568,000
+10.7%
9,378
+7.0%
0.00%0.0%
Q3 2018$513,000
+31.2%
8,766
+0.7%
0.00%0.0%
Q2 2018$391,000
+2.4%
8,708
+1.2%
0.00%0.0%
Q1 2018$382,000
-1.0%
8,607
-3.4%
0.00%0.0%
Q4 2017$386,000
-8.7%
8,909
-1.9%
0.00%0.0%
Q3 2017$423,000
-14.7%
9,083
-9.4%
0.00%0.0%
Q2 2017$496,000
-14.8%
10,028
-5.6%
0.00%0.0%
Q1 2017$582,000
-6.1%
10,628
-4.5%
0.00%0.0%
Q4 2016$620,000
+18.8%
11,128
-2.6%
0.00%0.0%
Q3 2016$522,000
+15.5%
11,428
+0.9%
0.00%0.0%
Q2 2016$452,000
+24.9%
11,328
+8.9%
0.00%0.0%
Q1 2016$362,000
-7.7%
10,406
+14.0%
0.00%0.0%
Q4 2015$392,0000.0%9,127
+1.5%
0.00%0.0%
Q3 2015$392,000
-15.5%
8,9950.0%0.00%0.0%
Q2 2015$464,000
+70.0%
8,995
+29.1%
0.00%0.0%
Q1 2015$273,000
+4.6%
6,967
+3.0%
0.00%0.0%
Q4 2014$261,000
+9.7%
6,767
+0.4%
0.00%0.0%
Q3 2014$238,000
+33.7%
6,738
+2.1%
0.00%
Q2 2014$178,000
+21.9%
6,600
-23.1%
0.00%
Q1 2013$146,0008,5770.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2013
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 36,000$2,244,0002.71%
JW Asset Management, LLC 73,649$4,591,0002.36%
THB ASSET MANAGEMENT 87,491$5,453,0000.79%
RICE HALL JAMES & ASSOCIATES, LLC 315,972$19,695,0000.63%
EAM Global Investors LLC 22,789$1,420,0000.63%
Elk Creek Partners, LLC 73,936$4,608,0000.33%
Matarin Capital Management, LLC 69,964$4,361,0000.32%
EAM Investors, LLC 17,696$1,103,0000.27%
CADENCE CAPITAL MANAGEMENT LLC 37,196$2,318,0000.21%
Cavalier Investments, LLC 7,800$486,0000.20%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders